65 /100
HIGH RISK
Score updated May 30, 2026

ARMP — Armata Pharmaceuticals, Inc. Dilution Risk Tracker

Track ARMP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ARMP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
70
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
45%
💰 Capital Raise 55%
• Critical: only 2.2 months cash remaining
📉 Score Deterioration 50%
• Score rose 39 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔁 Convertible Conversion 15%
• Convertible debt present: 9.7% potential dilution
🔔 Track ARMP — Get forecast alerts →

💹 Market Data

Market Cap$299.93M
Shares Outstanding36.71M
Float11.32M
Cash$4.75M
Debt$373.67M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 65.4% shares (2025Q4 vs prior)
36 institutional holders · 1.25M shares
#1 VANGUARD GROUP INC 357.6K shares
#2 683 Capital Management, LLC 139.9K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 109.9K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest225.0K
Days to Cover2.9
% of Float2.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2023
xbrl XBRL WARRANT Dec 31, 2020
4 INSIDER TRANSACTION Mar 17, 2026
4 INSIDER TRANSACTION Mar 17, 2026
4 INSIDER TRANSACTION Mar 11, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ARMP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ARMP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ARMP
📊 ARMP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ARMP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.